People · Operator
Named in public records as an officer, director or promoter · active 2010–2020 · Pharmaceuticals, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| InCarda Therapeutics, Inc. | — | Pharmaceuticals | Series B | $66.3M | $856.6M | 2017 |
| BeneChill, Inc. | — | Other Health Care | Series A | $35.7M | $132.7M | 2010 |
| Nexstim Plc | — | Biotechnology | Seed | $3.7M | $166.4M | 2014 |
Johan Christenson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Johan Christenson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Annette Campbell-White | 1 | 11 |
| Isaac Cheng | 1 | 9 |
| Denise Barbut | 1 | 9 |
| Michael Berman | 1 | 7 |
| Alan Colowick | 1 | 7 |
| Andrew ElBardissi | 1 | 7 |
| Noah Kroloff | 1 | 6 |
| Casper Breum | 1 | 5 |
| Allan Rozenberg | 1 | 5 |
| Grace Colon | 1 | 4 |
| John Hoffman | 1 | 3 |
| Ken Charhut | 1 | 3 |
| John S. Patton | 1 | 3 |
| Rene Kuijten | 1 | 2 |
| John Hardin | 1 | 1 |
| Henri Hannula | 1 | 1 |
| Gustaf Jarnefelt | 1 | 1 |
| Katya ` Smirnyagina | 1 | 1 |
| Mikko Karvinen | 1 | 1 |
| Juha Vapaavuori | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.